by The U.S. medical foods market has grown significantly over the past decade, driven primarily by rising health consciousness and chronic disease prevalence. Medical foods are food products developed to provide dietary management of diseases or health conditions like diabetes, cancer, and respiratory illnesses under medical supervision. They typically come in powder, liquid, capsule or bar formats and are designed to address distinctive nutritional requirements for specific illnesses. Medical foods contain ingredients such as vitamins, minerals, amino acids, prebiotics, and diet-ready proteins that allow them to maintain, support, or supplement a patient’s daily diet.
The U.S. Medical foods Market is estimated to be valued at US$ 25722.45 Bn in 2024 and is expected to exhibit a CAGR of 21% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the U.S. medical foods are Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc. These players offer a diverse range of clinically-tested disease-specific formulations of proteins, fats, carbohydrates, vitamins and minerals targeting conditions such as depression, diabetes, PKU, Alzheimer’s disease and more.
The growing prevalence of chronic and lifestyle-induced diseases has led to increased demand for innovative medical food products. According to recent statistics, around 40% of Americans are estimated to have lifestyle-related ailments like obesity, high blood pressure and heart disease. Medical foods help optimize nutrition in these patients by addressing nutrient deficiencies that occur due to illness or medical therapies.
Major medical foods companies are expanding their geographical footprint to capitalize on rising global healthcare needs. For example, in 2022, Medipost launched operations in India to provide specialized nutrition for diabetes, chronic kidney disease and malnutrition. Other players are entering partnerships with regional healthcare providers and distributors to make their offerings more accessible worldwide.
Market Key Trends
Personalized nutrition based on genetic profiling is a major trend gaining traction in the medical foods space. Next-generation formulas tailored to an individual’s specific genetic traits, diet, lifestyle and clinical profile could further optimize health outcomes. Companies are investing in genome sequencing and big data analytics capabilities to develop personalized formulations targeted for disease management and prevention. This highly customized approach has the potential to transform the medical foods industry and make precision nutrition a mainstream clinical practice.
Porter’s Analysis
Threat of new entrants: The medical foods industry requires significant capital investments and regulatory know-how, limiting the threat of new competition.
Bargaining power of buyers: Individual consumers have little influence over price, as medical foods are usually prescribed and purchased through medical channels.
Bargaining power of suppliers: The medical foods industry relies on specialized ingredients and formulations, giving ingredient suppliers some power in negotiations.
Threat of new substitutes: Some medical conditions may be treated with alternative therapies, though medical foods target specific dietary needs mandated by a physician.
Competitive rivalry: Competition is strong among the leading medical foods companies to supply the major retailers and healthcare providers.
The United States dominates the U.S.Medical Foods Market Demand in terms of value, due to advanced healthcare infrastructure and large consumer base affected by various medical conditions. The western European region is also a major market, driven by rising prevalence of chronic diseases and growing demand for personalized nutrition solutions across major countries like Germany, France and the UK.
Asia Pacific is poised to be the fastest growing regional market over the forecast period. This can be attributed to improving access to healthcare, increasing lifestyle diseases, growing medical tourism industry and rising disposable incomes in developing countries like India and China. Fast economic development is allowing consumers in the region to spend more on specialized foods and supplements for disease management.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
